Industry update from AusBiotech and PwC
Thursday, 03 May, 2012
AusBiotech’s CEO, Dr Anna Lavelle and PricewaterhouseCoopers’ (PwC) Partner, Craig Lawn, sat down to discuss the state of the biotechnology and life sciences sector on webcast, including the impact of the R&D Tax Credit, changes in the market for capital as well as current and emerging trends.
View the webcast here.
The video is a regular production to coincide with the quarterly release of PwC’s BioForum and the latest edition was edition 39 Q3FY12. BioForum reports on the Australian and US pharmaceutical, biotechnology and medical devices markets and the broader life sciences industry.
As well as reviewing market performance, BioForum covers initial and secondary capital raisings, clinical milestones, partnerships and mergers and acquisitions.
This edition of the webcast features:
- Reflection on the past year [4:33 MIN]
-
- Impact of R&D Tax Credit [4:49 MIN]
-
- Changes in the market for capital [3:44 MIN]
-
- Trends [6:26 MIN]
Anti-inflammatory agent could decrease septic shock mortality
Researchers have discovered a naturally occurring blood protein — a type of...
Less penicillin needed to treat Strep A infection than we thought
It's never been known exactly how much penicillin prevents sore throats — the most...
Stress disrupts emotion control in mental illness
Acute stress may impair key brain functions involved in managing emotions — particularly in...
